The Real Time Polymerase Chain Reaction (PCR) Market was valued at USD 6.5 billion in 2024 and is projected to reach USD 12.3 billion by 2034, registering a CAGR of 6.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of infectious diseases, advancements in molecular diagnostics, and the rising demand for personalized medicine. The market is...